The cost of adjuvant chemotherapy in patients with early‐stage breast carcinoma

Cancer - Tập 104 Số 10 - Trang 2054-2062 - 2005
Nina Oestreicher1,2, Scott D. Ramsey3,4, Jeannine S. McCune1, Hannah M. Linden3,5, David L. Veenstra1
1Department of Pharmacy, University of Washington, Seattle, Washington
2Division of Research, Kaiser Permanente, Oakland, California
3Department of Medicine, University of Washington, Seattle, Washington
4Divison of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
5Seattle Cancer Care Alliance, Seattle, Washington

Tóm tắt

AbstractBACKGROUNDIn the U.S., the majority of premenopausal patients with early‐stage breast carcinoma are treated with adjuvant chemotherapy. However, to the authors' knowledge, there have been few formal analyses of adjuvant chemotherapy cost performed to date, especially in premenopausal women. The objective of the current study was to evaluate the direct medical cost of adjuvant chemotherapy in women with early‐stage breast carcinoma.METHODSThe attributable cost of adjuvant chemotherapy was evaluated by comparing the total cost of care for patients with breast carcinoma (cases) during the period from diagnosis to 9 months subsequent with the cost for age‐matched and gender‐matched control patients without breast carcinoma over an equivalent time period. The authors identified cases from a linked database of claims records from a managed care organization, and the Cancer Surveillance System registry. Controls were identified from the managed care organization from which the cases originated. Resource prices were based on reimbursements from the managed care organization.RESULTSThe attributable cost of adjuvant chemotherapy was estimated to be $23,019 (95% confidence interval, $19,596–$26,441), based on 1239 women. The cost appeared to decrease with increasing age at diagnosis, with total costs of $26,834, $19,889, and $17,098 for women < 50, 50–59, and ≥ 60 years, respectively. Also, costs were higher for regional versus local disease ($36,076 vs. $12,659), for women who had a mastectomy versus breast‐conserving surgery ($31,075 vs. $17,889), and for women who had no comorbidities versus ≥ 1 comorbidity ($23,606 vs. $21,340). Contributors to high chemotherapy cost included use of chemotherapy agents not included in clinical guidelines during the study period, use of supportive care agents, and hospitalizations.CONCLUSIONSThe attributable cost of adjuvant chemotherapy in patients with early‐stage breast carcinoma is significant. The integration of managed care claims data with clinical data from the Cancer Surveillance System registry offered a unique opportunity to derive more informative and accurate disease burden estimates in oncology. Cancer 2005. © 2005 American Cancer Society.

Từ khóa


Tài liệu tham khảo

Ries LAG, 2004, SEER cancer statistics review, 1975‐2001

10.1093/jnci/93.13.979

10.1200/JCO.2002.07.052

10.7326/0003-4819-138-2-200301210-00009

10.1093/jnci/94.21.1626

10.1097/01.GIM.0000170776.31248.75

Hornberger J, 2005, Economic analysis of targeting chemotherapy using a 21‐gene RT‐PCR assay in lymph‐node‐negative, estrogen‐receptor‐positive, early‐stage breast cancer, Am J Manag Care., 11, 313

Warren JL, 2002, Costs of treatment for elderly women with early‐stage breast cancer in fee‐for‐service settings, J Clin Oncol., 20, 307, 10.1200/JCO.2002.20.1.307

10.1093/jnci/87.6.417

10.1093/jnci/93.6.447

Hillner BE, 1992, A model of chemotherapy in node‐negative breast cancer, J Natl Cancer Inst Monogr., 143

Kattlove H, 1995, Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package, JAMA., 273, 142, 10.1001/jama.1995.03520260064034

10.1097/00005650-199508000-00007

10.3109/02841868809091783

10.1002/(SICI)1097-0142(19960715)78:2<300::AID-CNCR17>3.0.CO;2-#

Hennekens C, 1987, Epidemiology in medicine

10.1016/0021-9681(87)90171-8

10.1016/0895-4356(92)90133-8

Young JL, 2001, SEER summary staging manual ‐ 2000: codes and coding instructions

10.1097/00005650-200208001-00008

10.1016/0895-4356(96)89259-6

10.2307/2533947

10.1093/oso/9780195108248.001.0001

Fireman BH, 1997, Cost of care for cancer in a health maintenance organization, Health Care Financ Rev., 18, 51

10.1056/NEJMoa021967

Thông tin
Thông tin xuất bản

Cancer

Tập 104 Số 10

2054-2062

Thông tin tác giả